TGFB1 and neoplasm: Although GEMM have been used to identify key immunoprotective cells and pathways that are suppressed during immunoediting (DuPage et al, 2012) or immunosuppressive cells and pathways, such as TGFβ production (Donkor et al, 2011), so far our study is the only genome-wide study of tumor immunoediting in a GEMM.